End of the line for Genfit's experimental NASH drug

23rd July 2020 Uncategorised 0

Development of elafibranor will be discontinued for NASH, with the company now focusing on its future as a treatment for PBC

More: End of the line for Genfit's experimental NASH drug
Source: News